Skip to main content
Clinical Trials/NCT06204848
NCT06204848
Completed
Not Applicable

Acquisition of Imaging Data of Vitreous Opacities in Human Eyes Using a Non-Invasive Imaging Device

PulseMedica1 site in 1 country44 target enrollmentNovember 12, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Floaters
Sponsor
PulseMedica
Enrollment
44
Locations
1
Primary Endpoint
Successful capture of SLO and OCT imaging data of SVOs for algorithm development
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

The goal of this clinical trial is to capture imaging data of eye floaters in the population to build an imaging database to learn more about them in. Participants will imaged with an investigational ophthalmic imaging device to capture images of their floaters.

Registry
clinicaltrials.gov
Start Date
November 12, 2024
End Date
July 31, 2025
Last Updated
7 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
PulseMedica
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Aged 18 years or older
  • Symptomatic vitreous opacities (floaters) in vision
  • Clear ocular media, to allow a clear view of the vitreous for the SVO-ID

Exclusion Criteria

  • Younger than 18 years of age
  • Presence of vitreous hemorrhage
  • Cataract Grade 3 and above
  • Opacification of lens, cornea, or vitreous
  • Diagnosis of narrow angle glaucoma
  • Refractive error is outside the range of -6D to+3D
  • Astigmatism is outside the range of +/-2D of cylinder

Outcomes

Primary Outcomes

Successful capture of SLO and OCT imaging data of SVOs for algorithm development

Time Frame: Through study completion, an average of 6-8 months

Successful collection of SLO and OCT imaging data

Secondary Outcomes

  • Collection of patient-reported symptoms(Through study completion, an average of 6-8 months)

Study Sites (1)

Loading locations...

Similar Trials